Fremanezumab (Anti-CALCA / CGRP)
Fremanezumab (Anti-CALCA / CGRP) is a humanized IgG2a monoclonal antibody that selectively and potently targets calcitonin gene-related peptide (CGRP). Fremanezumab has the potential for chronic migraine research.. MW: 145.5 kD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2791 |
| Sku # | A2791-1mg*25 |
| Pricing | 1mg*25, $2970.00 |